A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia
Sandra Viz-Lasheras,Alberto Gomez-Carballa,Jacobo Pardo-Seco,Xabier Bello,Irene Rivero-Calle,Ana Isabel Dacosta,Myrsini Kaforou,Dominic Coote,Aubrey Cunnington,Marieke Emonts,Jethro Herberg,Victoria Wright,Enitan D Carrol,Stephane Paulus,Werner Zenz,Daniela Kohlfurst,Michiel van der Flier,Ronald de Groot,Luregn J Schlapbach,Philipp Agyeman,Andrew Pollard,Colin Fink,Taco Kuijpers,Suzanne Anderson,Cristina Calvo,Maria del Carmen Martinez-Padilla,Ana Perez-Aragon,Esteban Gomez-Sanchez,Juan Valencia-Ramos,Francisco Gimenez-Sanchez,Paula Alonso-Quintela,Laura Moreno-Galarraga,Ulrich von Both,Marko Pokorn,Dace Zavadska,Maria Tsolia,Henriette A Moll,Michael Levin,Federico Martinon-Torres,Antonio Salas
DOI: https://doi.org/10.1101/2024.11.04.24316062
2024-11-05
Abstract:Pneumonia stands as the primary cause of death among children under five, yet current diagnosis methods often result in inadequate or unnecessary treatments. Our research seeks to address this gap by identifying host transcriptomic biomarkers in the blood of children with definitive viral and bacterial pneumonia. We performed RNA sequencing on 192 prospectively collected whole blood samples, including 38 controls and 154 pneumonia cases, uncovering a 5-transcript signature (genes FAM20A, BAG3, TDRD9, MXRA7 and KLF14) that effectively distinguishes bacterial from viral pneumonia (AUC: 0.95 [0.88-1.00]) Initial validation using combined definitive and probable cases yielded an AUC of 0.87 [0.77-0.97], while full validation in a new prospective cohort of 32 patients achieved an AUC of 0.92 [0.83-1]. This robust signature holds significant potential to enhance diagnostics accuracy for pediatric pneumonia, reducing diagnostic delays and unnecessary treatments, and potentially transforming clinical practice.